Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

HKG/2325 stock hub

HKG/2325 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

HKG/2325is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
462.4M
Hong Kong Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
HKG/2325
In the news

Latest news · HKG/2325

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 11.7P50 18.9P75 41.4
Trailing P/E142.3
P25 10.7P50 17.9P75 38.5
ROE0.3
P25 -14.7P50 2P75 9.4
ROIC33.5
P25 -10.4P50 1.9P75 10.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All HKG/2325 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
204
Groups with data
11
Currency
CNY
Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Cayman Islands
Country code
HK
Employees
1,064
Employees Change
-185%
Employees Change Percent
-14.81
Enterprise value
HKD -655.4M
Exchange
Hong Kong Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Diagnostics & Research
Isin
KYG9889T1067
Last refreshed
2026-05-10
Market cap
HKD 462.4M
Price
HKD 0.79
Price currency
HKD
Rev Per Employee
628,976.25x
Sector
Healthcare
Sic
8071
Symbol
hkg/2325
Website
https://www.yunkanghealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
0.7%
EV Earnings
-201.7x
EV/FCF
-2.34x
FCF yield
60.68%
P/B ratio
0.36x
P/E ratio
142.32x
P/S ratio
0.69x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
14.99%
EBITDA Margin
20.4%
FCF margin
41.93%
Gross margin
30.4%
Gross Profit
HKD 203.4M
Gross Profit Growth
-3.39%
Gross Profit Growth Q
-7.75%
Gross Profit Growth3 Y
-12.44%
Gross Profit Growth5 Y
-26.26%
Net Income
HKD 3.2M
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Net Income Growth5 Y
-56.69%
Pretax Margin
1.16%
Profit Margin
0.49%
Profit Per Employee
HKD 3,054
Profitable Years
1
ROA
1.89
Roa5y
1.7
ROCE
6.72
ROE
0.34
Roe5y
-0.85
ROIC
33.47
Roic5y
-0.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

17
MetricValue
Cagr1y
-73.51%
Cagr3y
-61.52%
Div CAGR3
-59.81%
EPS Growth Quarters
2
EPS Growth Years
1
EPS Growth5 Y
-56.18
FCF Growth
10%
FCF Growth3 Y
5.04%
FCF Growth5 Y
-2.11%
OCF Growth
16.53%
OCF Growth3 Y
6.05%
OCF Growth5 Y
-8.62%
Revenue Growth
-15.52x
Revenue Growth Q
-13.19x
Revenue Growth Years
0x
Revenue Growth3 Y
-8.87x
Revenue Growth5 Y
-26.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
HKD 0.2
Assets
HKD 3B
Cash
HKD 1.9B
Current Assets
HKD 2.6B
Current Liabilities
HKD 1.6B
Debt
HKD 770.4M
Debt EBITDA
HKD 5.25
Debt Equity
HKD 0.6
Debt FCF
HKD 2.75
Equity
HKD 1.3B
Interest Coverage
2.59
Liabilities
HKD 1.7B
Long Term Assets
HKD 490.3M
Long Term Liabilities
HKD 145.8M
Net Cash
HKD 1.1B
Net Cash By Market Cap
HKD 243
Net Cash Growth
52.97%
Net Debt EBITDA
HKD -8.25
Net Debt Equity
HKD -0.87
Net Debt FCF
HKD -4.01
Tangible Book Value
HKD 1.3B
Tangible Book Value Per Share
HKD 2.18
WACC
1.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.59
Inventory Turnover
27.9
Net Working Capital
HKD -402.3M
Quick ratio
1.5
Working Capital
HKD 917.1M
Working Capital Turnover
HKD 0.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
1.77%
Dividend per share
HKD 0
Last Dividend
HKD 0.02

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
-73.49%
200-day SMA
1.4
3Y total return
-94.3%
50-day SMA
0.81
50-day SMA vs 200-day SMA
50under200
All Time High
19.18
All Time High Change
-95.88%
All Time High Date
2022-07-07
All Time Low
0.65
All Time Low Change
21.54%
All Time Low Date
2026-03-02
ATR
0.05
Beta
-0.81
Beta1y
-0.55
Beta2y
-0.63
Ch YTD
-20.2
High
0.79
High52
4.84
High52 Date
2025-07-25
High52ch
-83.68%
Low
0.79
Low52
0.65
Low52 Date
2026-03-02
Low52ch
21.54%
Ma50ch
-3.02%
Price vs 200-day SMA
-43.65%
RSI
47.38
RSI Monthly
26.23
RSI Weekly
33.54
Sharpe ratio
-1.44x
Sortino ratio
-2.01
Total Return
1.77%
Tr YTD
-20.2
Tr1m
-4.82%
Tr1w
-4.82%
Tr3m
8.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
HKD 100.3M
Operating Income Growth5 Y
-11.71
Operating margin
14.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
145,313,154%
Net Borrowing
-435,395,625.7
Shares Insiders
39.34%
Shares Institutions
0%
Shares Out
585,344,654
Shares Qo Q
0%
Shares Yo Y
-1.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
HKD 278.2M
Average Volume
153,075x
Bv Per Share
2.2
CAPEX
HKD -55M
Ch1m
-4.82
Ch1w
-4.82
Ch1y
-73.49
Ch3m
8.22
Ch3y
-94.41
Ch6m
-26.85
Change
-1.25%
Change From Open
0
Close
0.8
Days Gap
-1.25
Depreciation Amortization
37,459,194.5
Dollar Volume
4,740
Earnings Date
2026-05-28
EBIT
HKD 100.3M
EBITDA
HKD 136.5M
EPS
HKD 0.01
F Score
8
FCF
HKD 280.6M
FCF EV Yield
-42.81x
FCF Per Share
HKD 0.48
Financing CF
-461,104,054
Fiscal Year End
December
Founded
2,008
Graham Number
0.52372
Graham Upside
-33.71
Income Tax
HKD 3.4M
Investing CF
348,933,894
Is Primary Listing
1
Last Earnings Date
2026-03-30
Last Report Date
2025-12-31
Lynch Fair Value
HKD 0.03
Lynch Upside
-96.49
Ma150
0.95
Ma150ch
-16.82%
Ma20
0.8
Ma20ch
-1.31%
Net CF
223,467,877
Next Earnings Date
2026-05-28
Open
0.79
P FCF Ratio
1.65
P OCF Ratio
1.38
Ppne
297,485,586.2
Price Date
2026-05-08
Price EBITDA
HKD 3.39
Ptbv Ratio
0.36
Relative Volume
0.04x
Revenue
669,230,729x
SBC By Revenue
0.36x
Share Based Comp
2,376,963
Tax By Revenue
0.51x
Tax Rate
44.09%
Tr6m
-26.85%
Volume
6,000
Z Score
1.32
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does HKG/2325 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2325 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-73.5%
S&P 500 1Y: n/a
3Y total return
-94.3%
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns HKG/2325?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+39.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-1.8%
Negative means the company is buying back shares.
Technical

HKG/2325 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.4
Neutral momentum band
Price vs 200-day MA
-43.7%
50/200-day relationship not available
Beta (5Y)
-0.81
Less volatile than the market
Sharpe ratio
-1.44
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About HKG/2325

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2325 stock rating?

hkg/2325 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2325 analysis?

The full report lives at /stocks/hkg/2325/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2325?

The latest report frames hkg/2325 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2325 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.